References (1)Lafontan M, Berlan M, Galitzky J, Montastruc JL
Beyond glycaemic control, GLP-1 agonists slow gastric emptying, promoting satiety and reducing appetite, which contributes to weight lossa beneficial effect in patients with obesity-related comorbidities
Fermented foods with probiotics may also support GLP-1 production through gut microbiome effects
The A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults with Obesity (SURMOUNT-MMO) trial assesses tirzepatide's impact on mortality and cardiovascular events in overweight or obese individuals
(Youre going to get blitzed, Koniver remembers Huberman saying.) On the podcast, Koniver said that almost everyone I could think of can benefit from peptides, and he highlighted an awesome, supersafe example called BPC-157